Navigation Links
Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
Date:8/27/2008

Pediatric Heart Center team, including Jacqueline M. Lamour, MD, Director of Pediatric Advanced Cardiac Therapy; Robert H. Pass, MD, Director of Pediatric Electrophysiology and Director of Pediatric Interventional Cardiology; and, Leo Lopez, MD, Director of Pediatric Noninvasive Imaging.

"The new pediatric heart transplant program at CHAM and its acclaimed cardiology team are important milestones for both Montefiore and Einstein, " said Allen M. Spiegel, MD, The Marilyn and Stanley M. Katz Dean at Albert Einstein College of Medicine. "Dr. Daphne Hsu and her team are outstanding clinical investigators and national leaders in the study and treatment of pediatric heart disease and transplantation. Their presence here is a tangible demonstration of our joint efforts to strengthen the links between Einstein research and Montefiore medicine."

"The pediatric heart transplant program and the addition of Dr. Hsu and her team greatly enhance our capabilities for treating any heart abnormality in children," said Philip Ozuah, MD, chairman of the Department of Pediatrics at Montefiore Medical Center and Einstein and physician-in-chief at CHAM. "The Children's Hospital at Montefiore has become a hospital of choice for patients and families from around the world seeking excellence and innovation in specialty care. Building one of America's finest children's hospitals in the Bronx reinforces Montefiore's commitment to improving the health of its community by offering our patients access to the highest quality care and services available anywhere in the world."

A graduate of the Yale School of Medicine, Dr. Hsu was previously Associate Director of the Pediatric Heart Transplant Program at New York Presbyterian's Morgan Stanley Children's Hospital, and Professor of Pediatrics and Director of Clinical Research at Columbia University's College of Physicians and Surgeons.

The Children's Hospital at Montefiore (CHAM) is one of the most clinically and technolo
'/>"/>

SOURCE Montefiore Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients
2. Novare Announces Completion of First Pediatric Single Port Spleen Removal Using RealHand(R) HD Instruments
3. FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
4. Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers
5. Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis
6. Childrens Brain Tumor Foundations Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research
7. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
8. Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
9. New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting
10. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
11. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...cal Incorporated (Nasdaq: VICL ) announced today...rom Merck & Co., Inc. based on Merck,s planned...stigational plasmid DNA (pDNA) cancer vaccine. The...livery technology and encodes human telomerase rev...f separate license agreement. , , "The brea...
(Date:11/28/2008)...- Eli Lilly and Company,(NYSE: LLY ) has withdr...rom,the U.S. Food and Drug Administration (FDA) f...t of chronic pain. Lilly plans to resubmit the app...rom a recently completed positive study,in chroni...cision does not affect duloxetine,s FDA-approved i...
(Date:11/26/2008)...KLIN, Mass., Nov. 26 PLC...d today that it has received full approval from th...U.S. pivotal trial to study the effectiveness of t... therapy in the prevention of Contrast-Induced Nep...LC,s request to expand their investigation from th...
(Date:11/25/2008)...re/ -- Proteolix, Inc., a,leader in the discovery...,protein degradation pathways in cancer and autoi...o ongoing Phase 2 clinical trials of carfilzomib i...ing 50th Annual Meeting of the,American Society o... new class,of specific proteasome inhibitors and ...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3LI COR Biosciences and Euthanex Corporation Provide Anesthesia System for Small Animal Imaging 8527 1LI COR Biosciences and Euthanex Corporation Provide Anesthesia System for Small Animal Imaging 8527 2DFG continues to strengthen biodiversity research 5543 1DFG continues to strengthen biodiversity research 5543 2Innovative strategies for war wounded 5538 1Innovative strategies for war wounded 5538 2Field hospital on a chip project awarded to nanoengineer from UC San Diego 5536 1Field hospital on a chip project awarded to nanoengineer from UC San Diego 5536 2Field hospital on a chip project awarded to nanoengineer from UC San Diego 5536 3
...lso Support Drug,s Efficacy at Improving Glycemic ...ications, CHICAGO, Ill., June 23, 2007 /PRNewswire...mercialization partner S2 Therapeutics,Inc., repo...trial,supporting the overall and cardiovascular sa...of bromocriptine mesylate) in subjects,with type 2...
...R CITY, Calif.--(BUSINESS WIRE)--June 25, 2007--Gi...that Study 103, a,Phase III clinical trial evaluat...R) (tenofovir disoproxil fumarate or tenofovir,DF)...itis B virus,(HBV) infection, met its primary effi...ferior to the company,s once-daily antiviral,drug ...
Other Medicine Technology:Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 2Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 3Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 4Phase IIIb Clinical Data Validate the Overall and Cardiovascular,Safety Profile of Cycloset (A Quick Release Formulation of,Bromocriptine Mesylate) in Patients with Type 2 Diabetes 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
(Date:12/1/2008)... Dec. 1 Actavis Group, the interna...unced that it has received approval from the U.S. ... Hydrochloride extended-release tablets (XL) 150mg... , Bupropion Hydrochloride extended-release ...h, are the generic equivalent of Wellbutrin XL(R) ...
(Date:12/1/2008)... , Ideas from U-M physician include economical... A bottle of cologne, a... and easy gifts to buy and wrap for the upcoming h...ng more healthy and beneficial to a loved one? Why...healthy around the holidays can be challenging, an...
(Date:12/1/2008)...PRNewswire/ -- Resurrection Health Care has been r...lthcare by Modern Healthcare,magazine. The nation...ing,homes, retirement communities, home health se...ices throughout the Chicago area. , Modern ...s health care,organizations nationwide that enabl...
(Date:12/1/2008)... 1 Prior generations often shared,...ents -- typically because,seniors didn,t live far...h,life expectancy having increased by an average ...mbered by health care concerns, which may make old...emselves. In the recently published,Evercare(R) S...
Breaking Medicine News(10 mins):Health News:Actavis Receives Approval of Generic Wellbutrin XL(R) 150mg in the U.S. 2Health News:Giving the Gift of Health This Holiday Season 2Health News:Giving the Gift of Health This Holiday Season 3Health News:Giving the Gift of Health This Holiday Season 4Health News:Resurrection Health Care Named One of Nation's 'Best Places to Work in Healthcare' 2Health News:Take Time to Care for the Caregiver 2
... the brain of youngsters, says a study, which stre... can do to them. // Thomas Heffernan, a psychologi...llege students for the research presented at the B...s annual conference in York, reported the online e...
...r still remains the best way to ensure patient s...ring the 85th General Session of the International...the University of California-Irvine presented two ...approaches to oral cancer detection, diagnostic sc...
...m Aberdeen University are on the brink of another ...s of lives,// by an early diagnosis of cancer, Alz...ther disorders. A prototype of an MRI scanner has...ferent images, compared to one image from current ...
...oon urged governments to join the anti-tuberculosi...n coming years as// the disease has become extreme...ng the importance of World TB Day on Saturday. The...tly reported about the rise in the extensively dru...
Other Medicine News:Health News:Novel Methods in Diagnosing Oral Cancer 2Health News:Breakthrough in MRI Scanning in the Near Future 2
15" overall length, 9" handle.
Gimmi Yasargil Aneurysm-Vessel-Clips
Yasargil Phynox Aneurysm Clips Standard
EDM Ventricular Drainage Kit, with Drip Chamber with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in
Medicine Products: